Skip to main content

Eckert & Ziegler

Eckert & Ziegler SE is a German medical technology and isotope engineering company specializing in the processing of radioisotopes and the manufacture of radiopharmaceutical components and sealed radiation sources. The group operates through two primary reporting segments: Medical, which supplies pharmaceutical-grade radioisotopes such as gallium-68, actinium-225, and lutetium-177 alongside automated synthesis modules for cancer diagnosis and targeted radioligand therapy, and Isotope Products, which provides calibration standards and industrial radiation sources for nuclear imaging, process control, and environmental monitoring. Revenue is driven primarily by global expansion in nuclear medicine oncology procedures, multi-year supply agreements with biopharmaceutical developers, and recurring sales of consumables and radiochemistry equipment to hospitals and clinics. Operating specialized production facilities across Europe and North America, Eckert & Ziegler employs over one thousand staff and generates annual revenue exceeding 300 million euros. Its regulatory licenses and isotope processing expertise create high barriers to entry in medical radiochemistry. Headquartered in Berlin, Germany, Eckert & Ziegler SE is publicly listed on the Frankfurt Stock Exchange under the ticker EUZ.

9 of the funds FundTelligence covers report a position in Eckert & Ziegler.

Sector
Health Care
Country
Germany
Funds holding it
9

Funds holding Eckert & Ziegler

Showing the 8 largest of 9 funds holding it.

Loading...